Login / Signup

Cerebrospinal fluid Alzheimer disease biomarkers for assessing cognitive and neuropsychiatric symptoms: Expanding the 'toolkit' in the psychiatrist's diagnostic armamentarium.

Dhamidhu EratneQiao-Xin LiSamantha M Loi Franzcp PhD MbbsMark WalterfangSarah FarrandAndrew EvansRamon MocellinColin L MastersSteven CollinsDennis Velakoulis
Published in: The Australian and New Zealand journal of psychiatry (2022)
Keyphrases
  • cerebrospinal fluid
  • mild cognitive impairment
  • sleep quality
  • physical activity